Nigel Santos MD

lifelong learner | stoic | Chief Resident PGH IM 2021 | PGH IM 2020 | La Salle Med 2016 | Avid interest in Vascular Medicine

[Heather L Gornik @heatherlgornik]

Reading scans today: beautiful example of sonographic appearance of a Dacron graft on vascular duplex. I call it the Ruffles potato chip sign with its prominent corrugations. PTFE will appear as two lines at each wall parallel to the flow channel #vascularultrasound #radiology

[Society for Vascular Medicine | SVM @SVM_tweets]

Join us tonight 🗓️ Monday, February 26, 2026 @ 8PM ET⏰ for #SVM Journal Club 📖 to review findings in CREST-2 🔈

#CREST2 #vascular @nigelsantosmd @LandisMD @herbaronowMD @AndrewDicksMD @bostonsci

[Society for Vascular Medicine | SVM @SVM_tweets]

#SVM is collaborating with #SVN (Society for Vascular Nursing) for virtual roundtable to discuss #CREST2 results.

Register asap and join @nigelsantosmd in the discussion 📖

[Society for Vascular Nursing (SVN) @for_svn]

SVN is collaborating with the Society for Vascular Medicine (SVM) for the Jan Roundtable! Hear about the Crest-2 Trial results. Register today! https://t.co/PS7Zl5yT3G

[Lukasz Zydzik @lukasz_zydzik]

55 yo woman.
Have you ever seen anything like that ?

#Echofirst #CardioTwitter
@argulian @alex1708ander @KemalogluOz @DrRajeshG1 @iamritu @dr_benoy_n_shah @purviparwani @echo_stepbystep @JGrapsa @papadocardio

[Bryan Elvambuena @iskolinian21]

The University of the Philippines - Philippine General Hospital Division of Cardiovascular Medicine is now accepting applications for the 3-year Fellowship in Adult Cardiovascular Medicine for year 2025. Application deadline: December 8, 2024

[Society for Vascular Medicine | SVM @SVM_tweets]

Cases on the rocks happening now!

Have you heard of Erdheim-Chester disease ??? #VSS2024

@AtefehGho

[Nigel Santos MD @nigelsantosmd]

Philippine delegates at the #VSS2024 #SVM 🇵🇭

[Society for Vascular Medicine | SVM @SVM_tweets]

What an INCREDIBLE PANEL of mentors for #SVM #VSS2024 #speedmentoring session!

@evratchford @PagingDrSolomon @adityasharmamd @kamalguptamd @YogenKanthi @DrLouMDPhD
#mentorship #vascular #medicine #MedTwitter #Cardiology

[Society for Vascular Medicine | SVM @SVM_tweets]

#Cardiovascular #kidney #metabolic (CKM) syndrome reflects interplay between #metabolic and cardiovascular risk factors such as #CAD, #CKD, and #PAD

#obesity #VSS2024 @VMJ_SVM
#mortality #MedTwitter

[Nigel Santos MD @nigelsantosmd]

Speed mentoring session at #VSS2024 #SVM @SVM_tweets

[The Heart @ZHeart11768530]

🔴Aortic Regurgitation: from mechanisms to management ⤵️STATE-OF-THE-ART #2024Review

🔹https://t.co/lNXRDaKVTD
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular

[European Society of Cardiology @escardio]

#ESCCongressVisuals for Hotline 8:

SCOFF - Fasting or no fasting before cardiac catherisation procedures

EARTH-STEMI - Complete vs. culprit-only revascularisation in older #STEMI patients

SENIOR RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial

#ESCCongress

[The Heart @ZHeart11768530]

🔴STEMI without ST elevations ❤️⤵️

🔹The Little ECG book by Dr. Ahmed Atta

Hard points became easier ❤️
#FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical

[Dr. AK 🇮🇳 @docakx]

🌟 ACUTE LIMB ISCHEMIA - Management Algorithm

2024 ESC Guidelines for the management of peripheral arterial and aortic diseases

[European Society of Cardiology @escardio]

#ESCCongressVisuals for Hotline 4

ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery

SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting

The TIGHT-K trial - Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery
has context menu

#ESCCongress

[Emanuele Monda @MondaEmanuele]

Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation

@ESC_Journals @escardio

https://t.co/7CG2NTxY1G

[The Heart @ZHeart11768530]

🔴When DOACS Should Not Be Standard Treatment: JACC State-of-the-Art #2024Review⤵️

🔹https://t.co/nbIsChvpfh
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical

[European Society of Cardiology @escardio]

#ESCCongressVisuals for Hotline 1 studies:
🔵Beta blocker interruption in patients with prior myocardial infarction: results of the ABYSS trial and effect on #BloodPressure and heart rate control
🔵STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial
🔵HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with #cardiomyopathy

#ESCCongress

[Davide Capodanno @DFCapodanno]

How many times have we seen this flow chart on the duration of DAPT change over the years? Let’s summarize the situation regarding class I recommendations (“must be done”) as reported in the new 2024 guidelines on chronic coronary syndromes:
- High bleeding risk patient: DAPT for 1-3 months.
- High ischemic risk patient with no high bleeding risk: DAPT for 6 months (alternatively 1-6 months in class IIb).
- Patient with neither high ischemic risk nor high bleeding risk: DAPT for 6 months (alternatively 1-3 months in class IIb).
I believe there is a missed opportunity for a recommendation regarding 'bi-risk' patients, but there is little evidence on this matter.
https://t.co/7RI6XRsdrd #ESCCongress